Nephra, founded in 2021 and headquartered in the United States, is pioneering in the realm of AI, Biotechnology, and Health Care. Their slogan, "Breakthrough preventative care for dialysis patients," encapsulates their mission: to revolutionize patient care through the integration of advanced technologies such as machine learning and artificial intelligence.
Nephra's primary offering is the development of real-time electrolyte monitoring tools designed specifically for dialysis patients. This innovation addresses significant gaps in patient care by aiming to minimize complications arising from infrequent monitoring, thereby supporting a shift towards personalized health management.
In their early stages, Nephra secured a $70.00K Pre Seed Round on 01 May 2021. This initial investment was led by prominent investors including VentureWell, Gies College of Business - University of Illinois Urbana-Champaign, and iVenture Accelerator, highlighting confidence in their potential to impact the healthcare sector meaningfully.